Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains

被引:357
作者
Wahrle, S
Das, P
Nyborg, AC
McLendon, C
Shoji, M
Kawarabayashi, T
Younkin, LH
Younkin, SG
Golde, TE
机构
[1] Mayo Clin Jacksonville, Dept Neurosci & Pharmacol, Jacksonville, FL 32224 USA
[2] Gunma Univ, Dept Neurol, Maebashi, Gumma 3718511, Japan
关键词
A beta; Alzheimer's disease; gamma-secretase; presenilin; lipid raft; cholesterol;
D O I
10.1006/nbdi.2001.0470
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Buoyant membrane fractions containing presenilin 1 (PS1), an essential component of the gamma-secretase complex, and APP CTFbeta, a gamma-secretase substrate, can be isolated from cultured cells and brain by several different fractionation procedures that are compatible with in vitro gamma-secretase assays. Analysis of these gradients for amyloid beta protein (Abeta) and CTFgamma production indicated that gamma-secretase activity is predominantly localized in these buoyant membrane microdomains. Consistent with this localization, we find that gamma-secretase activity is cholesterol dependent. Depletion of membrane cholesterol completely inhibits gamma-secretase cleavage; which can be restored by cholesterol replacement. Thus, altering cholesterol levels may influence the development of Alzheimer's disease (AD) by influencing production and deposition of Abeta within cholesterol rich membrane microdomains. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:11 / 23
页数:13
相关论文
共 42 条
[1]  
Avdulov NA, 1997, J NEUROCHEM, V69, P1746
[2]   Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast [J].
Bagnat, M ;
Keränen, S ;
Shevchenko, A ;
Shevchenko, A ;
Simons, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3254-3259
[3]  
Bodovitz S, 1996, J BIOL CHEM, V271, P4436
[4]   BETA-CYCLODEXTRIN INTERACTS WITH THE ALZHEIMER AMYLOID BETA-A4 PEPTIDE [J].
CAMILLERI, P ;
HASKINS, NJ ;
HOWLETT, DR .
FEBS LETTERS, 1994, 341 (2-3) :256-258
[5]   Acceleration of amyloid fibril formation by specific binding of A beta-(1-40) peptide to ganglioside-containing membrane vesicles [J].
ChooSmith, LP ;
GarzonRodriguez, W ;
Glabe, CG ;
Surewicz, WK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :22987-22990
[6]   Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins [J].
DeStrooper, B ;
Beullens, M ;
Contreras, B ;
Levesque, L ;
Craessaerts, K ;
Cordell, B ;
Moechars, D ;
Bollen, M ;
Fraser, P ;
StGeorgeHyslop, P ;
VanLeuven, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3590-3598
[7]   Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo [J].
Fassbender, K ;
Simons, M ;
Bergmann, C ;
Stroick, M ;
Lütjohann, D ;
Keller, P ;
Runz, H ;
Kühl, S ;
Bertsch, T ;
von Bergmannn, K ;
Hennerici, M ;
Beyreuther, K ;
Hartmann, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5856-5861
[8]   The role of cholesterol in the biosynthesis of β-amyloid. [J].
Frears, ER ;
Stephens, DJ ;
Walters, CE ;
Davies, H ;
Austen, BM .
NEUROREPORT, 1999, 10 (08) :1699-1705
[9]   Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts [J].
Georgakopoulos, A ;
Marambaud, P ;
Efthimiopoulos, S ;
Shioi, J ;
Cui, W ;
Li, HC ;
Schütte, M ;
Gordon, R ;
Holstein, GR ;
Martinelli, G ;
Mehta, P ;
Friedrich, VL ;
Robakis, NK .
MOLECULAR CELL, 1999, 4 (06) :893-902
[10]   Presenilins as therapeutic targets for the treatment of Alzheimer's disease [J].
Golde, TE ;
Younkin, SG .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) :264-269